                         SEQUENCE LISTING

<110>  A2 Biotherapeutics, Inc.
 
<120>  POLYPEPTIDES TARGETING MAGE-A3 PEPTIDE-MHC COMPLEXES AND METHODS 
       OF USE THEREOF

<130>  A2BI-013/01WO 331656-2060

<150>  US 62/981,940
<151>  2020-02-26

<150>  US 63/076,123
<151>  2020-09-09

<160>  383   

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  1

Phe Leu Trp Gly Pro Arg Ala Leu Val 
1               5                   


<210>  2

<400>  2
000

<210>  3

<400>  3
000

<210>  4

<400>  4
000

<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000364 mAb1 heavy chain CDR VH-1

<400>  5

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  6
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000364 mAb1 heavy chain CDR VH-2

<400>  6

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000364 mAb1 heavy chain CDR VH-3

<400>  7

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  8
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000364 mAb1 light chain CDR VL-1

<400>  8

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000364 mAb1 light chain CDR VL-2

<400>  9

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000364 mAb1 light chain CDR VL-3

<400>  10

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  11
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000364 mAb1 VH full length

<400>  11

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  12
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000364 mAb1 VL full length

<400>  12

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000365 mAb2 mAb1 heavy chain CDR VH-1

<400>  13

Glu Leu Ser Met His 
1               5   


<210>  14
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000365 mAb2 mAb1 heavy chain CDR VH-2

<400>  14

Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  15
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000365 mAb2 mAb1 heavy chain CDR VH-3

<400>  15

Cys Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp 
1               5                   10                  15      


Ile Trp 
        


<210>  16
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000365 mAb2 light chain CDR VL-1

<400>  16

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000365 mAb2 light chain CDR VL-2

<400>  17

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000365 mAb2 light chain CDR VL-3

<400>  18

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  19
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000365 mAb2 VH full length

<400>  19

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  20
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000365 mAb2 VL full length

<400>  20

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  21
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000366 mAb3 mAb1 heavy chain CDR VH-1

<400>  21

Asp Tyr Tyr Met His 
1               5   


<210>  22
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000366 mAb3 mAb1 heavy chain CDR VH-2

<400>  22

Leu Val Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Glu Lys Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000366 mAb3 mAb1 heavy chain CDR VH-3

<400>  23

Cys Ala Leu Leu Ser Gly Trp Tyr Ile Asp Ala Phe Asp Ile Trp 
1               5                   10                  15  


<210>  24
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000366 mAb3 light chain CDR VL-1

<400>  24

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000366 mAb3 light chain CDR VL-2

<400>  25

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000366 mAb3 light chain CDR VL-3

<400>  26

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  27
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000366 mAb3 VH full length

<400>  27

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Thr Val Lys Ile Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Tyr Met His Trp Val Gln Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Leu Val Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Glu Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Leu Leu Ser Gly Trp Tyr Ile Asp Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  28
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000366 mAb3 VL full length

<400>  28

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  29
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000367 mAb4 mAb1 heavy chain CDR VH-1

<400>  29

Ser Ser Asn Trp Trp Gly 
1               5       


<210>  30
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000367 mAb4 mAb1 heavy chain CDR VH-2

<400>  30

Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  31
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000367 mAb4 mAb1 heavy chain CDR VH-3

<400>  31

Cys Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  32
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000367 mAb4 light chain CDR VL-1

<400>  32

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  33
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000367 mAb4 light chain CDR VL-2

<400>  33

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  34
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000367 mAb4 light chain CDR VL-3

<400>  34

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  35
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000367 mAb4 VH full length

<400>  35

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  36
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000367 mAb4 VL full length

<400>  36

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  37
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000368 mAb5 mAb1 heavy chain CDR VH-1

<400>  37

Ser Tyr Asp Met His 
1               5   


<210>  38
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000368 mAb5 mAb1 heavy chain CDR VH-2

<400>  38

Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys Gly 
1               5                   10                  15      


<210>  39
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000368 mAb5 mAb1 heavy chain CDR VH-3

<400>  39

Cys Ala Arg Asp Leu Tyr Tyr Asp Ile Leu Thr Gly Tyr Pro Asp Ala 
1               5                   10                  15      


Phe Asp Ile Trp 
            20  


<210>  40
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000368 mAb5 light chain CDR VL-1

<400>  40

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  41
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000368 mAb5 light chain CDR VL-2

<400>  41

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  42
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000368 mAb5 light chain CDR VL-3

<400>  42

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  43
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000368 mAb5 VH full length

<400>  43

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Leu Tyr Tyr Asp Ile Leu Thr Gly Tyr Pro Asp Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  44
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000368 mAb5 VL full length

<400>  44

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  45
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000369 mAb6 mAb1 heavy chain CDR VH-1

<400>  45

Asp Tyr Ala Met His 
1               5   


<210>  46
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000369 mAb6 mAb1 heavy chain CDR VH-2

<400>  46

Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  47
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000369 mAb6 mAb1 heavy chain CDR VH-3

<400>  47

Cys Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp 
1               5                   10                  15      


Val Trp 
        


<210>  48
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000369 mAb6 light chain CDR VL-1

<400>  48

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  49
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000369 mAb6 light chain CDR VL-2

<400>  49

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  50
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000369 mAb6 light chain CDR VL-3

<400>  50

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  51
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000369 mAb6 VH full length

<400>  51

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  52
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000369 mAb6 VL full length

<400>  52

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  53
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000370 mAb7 mAb1 heavy chain CDR VH-1

<400>  53

Ser Ser Ser Tyr Tyr Trp Gly 
1               5           


<210>  54
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000370 mAb7 mAb1 heavy chain CDR VH-2

<400>  54

Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  55
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000370 mAb7 mAb1 heavy chain CDR VH-3

<400>  55

Cys Ala Arg Arg Asp Gly Gly Asn Trp Tyr Phe Asp Leu Trp 
1               5                   10                  


<210>  56
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000370 mAb7 light chain CDR VL-1

<400>  56

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  57
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000370 mAb7 light chain CDR VL-2

<400>  57

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  58
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000370 mAb7 light chain CDR VL-3

<400>  58

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  59
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000370 mAb7 VH full length

<400>  59

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg Asp Gly Gly Asn Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  60
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000370 mAb7 VL full length

<400>  60

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  61
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000371 mAb8 mAb1 heavy chain CDR VH-1

<400>  61

Ser Ser Asn Trp Trp Gly 
1               5       


<210>  62
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000371 mAb8 mAb1 heavy chain CDR VH-2

<400>  62

Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  63
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000371 mAb8 mAb1 heavy chain CDR VH-3

<400>  63

Cys Ala Arg Asn Thr Asp Pro Gln Leu Glu Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15      


<210>  64
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000371 mAb8 light chain CDR VL-1

<400>  64

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  65
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000371 mAb8 light chain CDR VL-2

<400>  65

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  66
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000371 mAb8 light chain CDR VL-3

<400>  66

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  67
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000371 mAb8 VH full length

<400>  67

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asn Thr Asp Pro Gln Leu Glu Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  68
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000371 mAb8 VL full length

<400>  68

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  69
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000372 mAb9 mAb1 heavy chain CDR VH-1

<400>  69

Ser Tyr Ser Met Asn 
1               5   


<210>  70
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000372 mAb9 mAb1 heavy chain CDR VH-2

<400>  70

Tyr Ile Ser Ser Ser Ser Ser Thr Ile Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  71
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000372 mAb9 mAb1 heavy chain CDR VH-3

<400>  71

Cys Ala Arg Asp Asp Tyr Ser Ser Glu Tyr Phe Gln His Trp 
1               5                   10                  


<210>  72
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000372 mAb9 light chain CDR VL-1

<400>  72

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  73
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000372 mAb9 light chain CDR VL-2

<400>  73

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  74
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000372 mAb9 light chain CDR VL-3

<400>  74

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  75
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000372 mAb9 VH full length

<400>  75

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Ser Ser Thr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Asp Tyr Ser Ser Glu Tyr Phe Gln His Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  76
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000372 mAb9 VL full length

<400>  76

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  77
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000373 mAb1 V10 mAb1 heavy chain CDR VH-1

<400>  77

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  78
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000373 mAb1 V10 mAb1 heavy chain CDR VH-2

<400>  78

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  79
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000373 mAb1 V10 mAb1 heavy chain CDR VH-3

<400>  79

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  80
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000373 mAb1 V10 light chain CDR VL-1

<400>  80

Arg Ala Ser Gln Ile Tyr Val Ser Ser Tyr Leu Asn 
1               5                   10          


<210>  81
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000373 mAb1 V10 light chain CDR VL-2

<400>  81

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  82
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000373 mAb1 V10 light chain CDR VL-3

<400>  82

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  83
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000373 mAb1 V10 VH full length

<400>  83

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  84
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000373 mAb1 V10 VL full length

<400>  84

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ile Tyr Val Ser Ser 
            20                  25                  30          


Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  85
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000374 mAb1 V12 mAb1 heavy chain CDR VH-1

<400>  85

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  86
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000374 mAb1 V12 mAb1 heavy chain CDR VH-2

<400>  86

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  87
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000374 mAb1 V12 mAb1 heavy chain CDR VH-3

<400>  87

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  88
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000374 mAb1 V12 light chain CDR VL-1

<400>  88

Arg Ala Ser Gln Ser Ala Ser Phe Val Ser Ser Tyr Leu Asn 
1               5                   10                  


<210>  89
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000374 mAb1 V12 light chain CDR VL-2

<400>  89

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  90
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000374 mAb1 V12 light chain CDR VL-3

<400>  90

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  91
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000374 mAb1 V12 VH full length

<400>  91

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  92
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000374 mAb1 V12 VL full length

<400>  92

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ala Ser Phe Val 
            20                  25                  30          


Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
                85                  90                  95      


Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  93
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000375 mAb1 V19 mAb1 heavy chain CDR VH-1

<400>  93

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  94
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000375 mAb1 V19 mAb1 heavy chain CDR VH-2

<400>  94

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  95
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000375 mAb1 V19 mAb1 heavy chain CDR VH-3

<400>  95

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  96
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000375 mAb1 V19 light chain CDR VL-1

<400>  96

Arg Ala Ser Gln Pro Tyr Val Ser Ser Tyr Leu Asn 
1               5                   10          


<210>  97
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000375 mAb1 V19 light chain CDR VL-2

<400>  97

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  98
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000375 mAb1 V19 light chain CDR VL-3

<400>  98

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  99
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000375 mAb1 V19 VH full length

<400>  99

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  100
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000375 mAb1 V19 VL full length

<400>  100

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Pro Tyr Val Ser Ser 
            20                  25                  30          


Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  101
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000376 mAb1 V20 mAb1 heavy chain CDR VH-1

<400>  101

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  102
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000376 mAb1 V20 mAb1 heavy chain CDR VH-2

<400>  102

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  103
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000376 mAb1 V20 mAb1 heavy chain CDR VH-3

<400>  103

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  104
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000376 mAb1 V20 light chain CDR VL-1

<400>  104

Arg Ala Ser Gln Leu Tyr Val Ser Ser Tyr Leu Asn 
1               5                   10          


<210>  105
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000376 mAb1 V20 light chain CDR VL-2

<400>  105

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  106
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000376 mAb1 V20 light chain CDR VL-3

<400>  106

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  107
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000376 mAb1 V20 VH full length

<400>  107

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  108
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000376 mAb1 V20 VL full length

<400>  108

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Leu Tyr Val Ser Ser 
            20                  25                  30          


Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  109
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000377 mAb1 V21 mAb1 heavy chain CDR VH-1

<400>  109

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  110
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000377 mAb1 V21 mAb1 heavy chain CDR VH-2

<400>  110

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  111
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000377 mAb1 V21 mAb1 heavy chain CDR VH-3

<400>  111

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  112
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000377 mAb1 V21 light chain CDR VL-1

<400>  112

Arg Ala Ser His Pro Tyr Val Ser Ser Tyr Leu Asn 
1               5                   10          


<210>  113
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000377 mAb1 V21 light chain CDR VL-2

<400>  113

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  114
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000377 mAb1 V21 light chain CDR VL-3

<400>  114

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  115
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000377 mAb1 V21 VH full length

<400>  115

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  116
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000377 mAb1 V21 VL full length

<400>  116

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser His Pro Tyr Val Ser Ser 
            20                  25                  30          


Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  117
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000378 mAb1 V22 mAb1 heavy chain CDR VH-1

<400>  117

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  118
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000378 mAb1 V22 mAb1 heavy chain CDR VH-2

<400>  118

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  119
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000378 mAb1 V22 mAb1 heavy chain CDR VH-3

<400>  119

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  120
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000378 mAb1 V22 light chain CDR VL-1

<400>  120

Arg Ala Ser Gln Ser Thr Leu Tyr Val Ser Ser Tyr Leu Asn 
1               5                   10                  


<210>  121
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000378 mAb1 V22 light chain CDR VL-2

<400>  121

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  122
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000378 mAb1 V22 light chain CDR VL-3

<400>  122

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  123
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000378 mAb1 V22 VH full length

<400>  123

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  124
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000378 mAb1 V22 VL full length

<400>  124

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Thr Leu Tyr Val 
            20                  25                  30          


Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
                85                  90                  95      


Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  125
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000379 mAb1 V23 mAb1 heavy chain CDR VH-1

<400>  125

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  126
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000379 mAb1 V23 mAb1 heavy chain CDR VH-2

<400>  126

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  127
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000379 mAb1 V23 mAb1 heavy chain CDR VH-3

<400>  127

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  128
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000379 mAb1 V23 light chain CDR VL-1

<400>  128

Arg Ala Ser Gln Ser Ser Asp Leu Val Ser Ser Tyr Leu Asn 
1               5                   10                  


<210>  129
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000379 mAb1 V23 light chain CDR VL-2

<400>  129

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  130
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000379 mAb1 V23 light chain CDR VL-3

<400>  130

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  131
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000379 mAb1 V23 VH full length

<400>  131

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  132
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000379 mAb1 V23 VL full length

<400>  132

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ser Asp Leu Val 
            20                  25                  30          


Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
                85                  90                  95      


Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  133
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000380 mAb1 V24 mAb1 heavy chain CDR VH-1

<400>  133

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  134
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000380 mAb1 V24 mAb1 heavy chain CDR VH-2

<400>  134

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  135
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000380 mAb1 V24 mAb1 heavy chain CDR VH-3

<400>  135

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  136
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000380 mAb1 V24 light chain CDR VL-1

<400>  136

Arg Ala Ser Gln Ser Thr Leu Leu Val Ser Ser Tyr Leu Asn 
1               5                   10                  


<210>  137
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000380 mAb1 V24 light chain CDR VL-2

<400>  137

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  138
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000380 mAb1 V24 light chain CDR VL-3

<400>  138

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  139
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000380 mAb1 V24 VH full length

<400>  139

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  140
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000380 mAb1 V24 VL full length

<400>  140

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Thr Leu Leu Val 
            20                  25                  30          


Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
                85                  90                  95      


Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  141
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000456 mAb1 V25 mAb1 heavy chain CDR VH-1

<400>  141

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  142
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000456 mAb1 V25 mAb1 heavy chain CDR VH-2

<400>  142

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  143
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000456 mAb1 V25 mAb1 heavy chain CDR VH-3

<400>  143

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  144
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000456 mAb1 V25 light chain CDR VL-1

<400>  144

Arg Ala Ser Gln Ser Tyr Val Ser Gly Tyr Leu Asn 
1               5                   10          


<210>  145
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000456 mAb1 V25 light chain CDR VL-2

<400>  145

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  146
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000456 mAb1 V25 light chain CDR VL-3

<400>  146

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  147
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000456 mAb1 V25 VH full length

<400>  147

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  148
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000456 mAb1 V25 VL full length

<400>  148

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Tyr Val Ser Gly 
            20                  25                  30          


Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  149
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000457 mAb1 V26 mAb1 heavy chain CDR VH-1

<400>  149

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  150
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000457 mAb1 V26 mAb1 heavy chain CDR VH-2

<400>  150

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  151
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000457 mAb1 V26 mAb1 heavy chain CDR VH-3

<400>  151

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  152
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000457 mAb1 V26 light chain CDR VL-1

<400>  152

Arg Ala Ser Gln Phe Gly Phe Phe Val Gly Gly Tyr Leu Asn 
1               5                   10                  


<210>  153
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000457 mAb1 V26 light chain CDR VL-2

<400>  153

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  154
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000457 mAb1 V26 light chain CDR VL-3

<400>  154

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  155
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000457 mAb1 V26 VH full length

<400>  155

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  156
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000457 mAb1 V26 VL full length

<400>  156

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Phe Gly Phe Phe Val 
            20                  25                  30          


Gly Gly Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
                85                  90                  95      


Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  157
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000458 mAb2 V27 mAb1 heavy chain CDR VH-1

<400>  157

Glu Leu Ser Met His 
1               5   


<210>  158
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000458 mAb2 V27 mAb1 heavy chain CDR VH-2

<400>  158

Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  159
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000458 mAb2 V27 mAb1 heavy chain CDR VH-3

<400>  159

Cys Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp 
1               5                   10                  15      


Ile Trp 
        


<210>  160
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000458 mAb2 V27 light chain CDR VL-1

<400>  160

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  161
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000458 mAb2 V27 light chain CDR VL-2

<400>  161

Ala Ala Ser Ser Leu His Tyr Val Ser 
1               5                   


<210>  162
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000458 mAb2 V27 light chain CDR VL-3

<400>  162

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  163
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000458 mAb2 V27 VH full length

<400>  163

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  164
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000458 mAb2 V27 VL full length

<400>  164

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu His Tyr Val Ser Gly Val Pro Ser Arg Phe 
    50                  55                  60                  


Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu 
65                  70                  75                  80  


Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr 
                85                  90                  95      


Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  165
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000459 mAb2 V29 mAb1 heavy chain CDR VH-1

<400>  165

Glu Leu Ser Met His 
1               5   


<210>  166
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000459 mAb2 V29 mAb1 heavy chain CDR VH-2

<400>  166

Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  167
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000459 mAb2 V29 mAb1 heavy chain CDR VH-3

<400>  167

Cys Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp 
1               5                   10                  15      


Ile Trp 
        


<210>  168
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000459 mAb2 V29 light chain CDR VL-1

<400>  168

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  169
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000459 mAb2 V29 light chain CDR VL-2

<400>  169

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  170
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000459 mAb2 V29 light chain CDR VL-3

<400>  170

Gln Gln Ser Trp Ala Ser Thr Pro Leu Thr 
1               5                   10  


<210>  171
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000459 mAb2 V29 VH full length

<400>  171

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  172
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000459 mAb2 V29 VL full length

<400>  172

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Trp Ala Ser Thr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  173
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000381 mAb4 V15 mAb1 heavy chain CDR VH-1

<400>  173

Ser Ser Asn Trp Trp Gly 
1               5       


<210>  174
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000381 mAb4 V15 mAb1 heavy chain CDR VH-2

<400>  174

Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  175
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000381 mAb4 V15 mAb1 heavy chain CDR VH-3

<400>  175

Cys Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  176
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000381 mAb4 V15 light chain CDR VL-1

<400>  176

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  177
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000381 mAb4 V15 light chain CDR VL-2

<400>  177

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  178
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000381 mAb4 V15 light chain CDR VL-3

<400>  178

Gln Gln Ser Tyr Ser Phe Val Leu Thr 
1               5                   


<210>  179
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000381 mAb4 V15 VH full length

<400>  179

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  180
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000381 mAb4 V15 VL full length

<400>  180

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Phe Val Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  181
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000382 mAb4 V16 mAb1 heavy chain CDR VH-1

<400>  181

Ser Ser Asn Trp Trp Gly 
1               5       


<210>  182
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000382 mAb4 V16 mAb1 heavy chain CDR VH-2

<400>  182

Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  183
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000382 mAb4 V16 mAb1 heavy chain CDR VH-3

<400>  183

Cys Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  184
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000382 mAb4 V16 light chain CDR VL-1

<400>  184

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  185
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000382 mAb4 V16 light chain CDR VL-2

<400>  185

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  186
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000382 mAb4 V16 light chain CDR VL-3

<400>  186

Gln Gln Ser Tyr Gly Tyr Val Leu Thr 
1               5                   


<210>  187
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000382 mAb4 V16 VH full length

<400>  187

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  188
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000382 mAb4 V16 VL full length

<400>  188

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Gly Tyr Val Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  189
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000383 mAb4 V17 mAb1 heavy chain CDR VH-1

<400>  189

Ser Ser Asn Trp Trp Gly 
1               5       


<210>  190
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000383 mAb4 V17 mAb1 heavy chain CDR VH-2

<400>  190

Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  191
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000383 mAb4 V17 mAb1 heavy chain CDR VH-3

<400>  191

Cys Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  192
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000383 mAb4 V17 light chain CDR VL-1

<400>  192

Arg Ala Ser Gln Ser Ile Gly Pro Phe Leu Ser Tyr Leu Asn 
1               5                   10                  


<210>  193
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000383 mAb4 V17 light chain CDR VL-2

<400>  193

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  194
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000383 mAb4 V17 light chain CDR VL-3

<400>  194

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  195
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000383 mAb4 V17 VH full length

<400>  195

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  196
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000383 mAb4 V17 VL full length

<400>  196

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Pro Phe 
            20                  25                  30          


Leu Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
                85                  90                  95      


Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  197
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000460 mAb4 V34 mAb1 heavy chain CDR VH-1

<400>  197

Ser Ser Asn Trp Trp Gly 
1               5       


<210>  198
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000460 mAb4 V34 mAb1 heavy chain CDR VH-2

<400>  198

Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  199
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000460 mAb4 V34 mAb1 heavy chain CDR VH-3

<400>  199

Cys Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  200
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000460 mAb4 V34 light chain CDR VL-1

<400>  200

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  201
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000460 mAb4 V34 light chain CDR VL-2

<400>  201

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  202
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000460 mAb4 V34 light chain CDR VL-3

<400>  202

Gln Gln Ser Trp Gly Thr Pro Leu Thr 
1               5                   


<210>  203
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000460 mAb4 V34 VH full length

<400>  203

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  204
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000460 mAb4 V34 VL full length

<400>  204

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Trp Gly Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  205
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000384 mAb6 V18 mAb1 heavy chain CDR VH-1

<400>  205

Asp Tyr Ala Met His 
1               5   


<210>  206
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000384 mAb6 V18 mAb1 heavy chain CDR VH-2

<400>  206

Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  207
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000384 mAb6 V18 mAb1 heavy chain CDR VH-3

<400>  207

Cys Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp 
1               5                   10                  15      


Val Trp 
        


<210>  208
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000384 mAb6 V18 light chain CDR VL-1

<400>  208

Arg Ala Ser Gln Ser Ile Ser Ser Gly Leu Ser Tyr Leu Asn 
1               5                   10                  


<210>  209
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000384 mAb6 V18 light chain CDR VL-2

<400>  209

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  210
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000384 mAb6 V18 light chain CDR VL-3

<400>  210

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  211
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000384 mAb6 V18 VH full length

<400>  211

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  212
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000384 mAb6 V18 VL full length

<400>  212

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Gly 
            20                  25                  30          


Leu Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
                85                  90                  95      


Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  213
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000461 mAb6 V36 mAb1 heavy chain CDR VH-1

<400>  213

Asp Tyr Ala Met His 
1               5   


<210>  214
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000461 mAb6 V36 mAb1 heavy chain CDR VH-2

<400>  214

Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  215
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000461 mAb6 V36 mAb1 heavy chain CDR VH-3

<400>  215

Cys Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp 
1               5                   10                  15      


Val Trp 
        


<210>  216
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000461 mAb6 V36 light chain CDR VL-1

<400>  216

Arg Ala Ser Gln Ser Ile Ser Ser Gly Val Ser Tyr Leu Asn 
1               5                   10                  


<210>  217
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000461 mAb6 V36 light chain CDR VL-2

<400>  217

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  218
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000461 mAb6 V36 light chain CDR VL-3

<400>  218

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  219
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000461 mAb6 V36 VH full length

<400>  219

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  220
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-000461 mAb6 V36 VL full length

<400>  220

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Gly 
            20                  25                  30          


Val Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
                85                  90                  95      


Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  221
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody heavy chain CDR1

<400>  221

Ser Gly Gly Tyr Ser Trp Ser 
1               5           


<210>  222
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody heavy chain CDR2

<400>  222

Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  223
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody heavy chain CDR3

<400>  223

Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  224
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody light chain CDR1


<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa is Gln or His

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is Ser, Pro, Ile, Leu or Phe

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Gly, Ala, Ser, Thr or is absent

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Phe, Ser, Asp, Leu or is absent

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa is Tyr, Phe, Leu or is absent

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa is Ile or Val

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa is Ser or Gly

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa is Ser or Gly

<400>  224

Arg Ala Ser Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Tyr Leu Asn 
1               5                   10                  


<210>  225
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody light chain CDR2

<400>  225

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  226
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody light chain CDR3

<400>  226

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  227
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody heavy chain CDR1

<400>  227

Glu Leu Ser Met His 
1               5   


<210>  228
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody heavy chain CDR2

<400>  228

Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  229
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody heavy chain CDR3

<400>  229

Cys Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp 
1               5                   10                  15      


Ile Trp 
        


<210>  230
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody light chain CDR1

<400>  230

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  231
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody light chain CDR2


<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Gln or His

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Tyr or is absent

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa is Val or is absent

<400>  231

Ala Ala Ser Ser Leu Xaa Xaa Xaa Ser 
1               5                   


<210>  232
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody light chain CDR3


<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa is Tyr or Trp

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is Ala or is absent

<400>  232

Gln Gln Ser Xaa Xaa Ser Thr Pro Leu Thr 
1               5                   10  


<210>  233
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR1

<400>  233

Ser Ser Asn Trp Trp Gly 
1               5       


<210>  234
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR2

<400>  234

Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser 
1               5                   10                  15      


<210>  235
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  235

Cys Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp 
1               5                   10                  15  


<210>  236
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  mAb4 variant VL-1


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Ser or Gly

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa is Pro or is absent

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa is Phe or is absent

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa is Leu or is absent

<400>  236

Arg Ala Ser Gln Ser Ile Xaa Xaa Xaa Xaa Ser Tyr Leu Asn 
1               5                   10                  


<210>  237
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  mAb4 variant VL-2

<400>  237

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  238
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  mAb4 variant VL-3


<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa is Tyr or Trp

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is Ser or Gly

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Phe, Tyr or Thr

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Val or Pro

<400>  238

Gln Gln Ser Xaa Xaa Xaa Xaa Leu Thr 
1               5                   


<210>  239
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR1

<400>  239

Asp Tyr Ala Met His 
1               5   


<210>  240
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR2

<400>  240

Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  241
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  241

Cys Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp 
1               5                   10                  15      


Val Trp 
        


<210>  242
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment light chain 
       CDR1


<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa is Gly or is absent

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa is Leu, Val or is absent

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa is Ser or is absent

<400>  242

Arg Ala Ser Gln Ser Ile Ser Ser Xaa Xaa Xaa Tyr Leu Asn 
1               5                   10                  


<210>  243
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment light chain 
       CDR2

<400>  243

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  244
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  mAb6 variant VL-3

<400>  244

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  245
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  signal peptide

<400>  245

Met Asp Met Arg Val Pro Ala Gln Leu Leu Gly Leu Leu Leu Leu Trp 
1               5                   10                  15      


Leu Arg Gly Ala Arg Cys 
            20          


<210>  246
<211>  245
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  246

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln 
                165                 170                 175     


Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu 
            180                 185                 190         


Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp 
        195                 200                 205             


Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr 
    210                 215                 220                 


Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr 
225                 230                 235                 240 


Lys Val Glu Ile Lys 
                245 


<210>  247
<211>  246
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  247

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Ile Tyr Val Ser Ser Tyr Leu Asn Trp Tyr Gln 
                165                 170                 175     


Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser 
            180                 185                 190         


Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr 
        195                 200                 205             


Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr 
    210                 215                 220                 


Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly 
225                 230                 235                 240 


Thr Lys Val Glu Ile Lys 
                245     


<210>  248
<211>  248
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  248

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Ser Ala Ser Phe Val Ser Ser Tyr Leu Asn Trp 
                165                 170                 175     


Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala 
            180                 185                 190         


Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser 
        195                 200                 205             


Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe 
    210                 215                 220                 


Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly 
225                 230                 235                 240 


Gly Gly Thr Lys Val Glu Ile Lys 
                245             


<210>  249
<211>  246
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  249

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Pro Tyr Val Ser Ser Tyr Leu Asn Trp Tyr Gln 
                165                 170                 175     


Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser 
            180                 185                 190         


Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr 
        195                 200                 205             


Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr 
    210                 215                 220                 


Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly 
225                 230                 235                 240 


Thr Lys Val Glu Ile Lys 
                245     


<210>  250
<211>  246
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  250

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Leu Tyr Val Ser Ser Tyr Leu Asn Trp Tyr Gln 
                165                 170                 175     


Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser 
            180                 185                 190         


Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr 
        195                 200                 205             


Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr 
    210                 215                 220                 


Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly 
225                 230                 235                 240 


Thr Lys Val Glu Ile Lys 
                245     


<210>  251
<211>  246
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  251

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser His Pro Tyr Val Ser Ser Tyr Leu Asn Trp Tyr Gln 
                165                 170                 175     


Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser 
            180                 185                 190         


Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr 
        195                 200                 205             


Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr 
    210                 215                 220                 


Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly 
225                 230                 235                 240 


Thr Lys Val Glu Ile Lys 
                245     


<210>  252
<211>  248
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  252

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Ser Thr Leu Tyr Val Ser Ser Tyr Leu Asn Trp 
                165                 170                 175     


Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala 
            180                 185                 190         


Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser 
        195                 200                 205             


Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe 
    210                 215                 220                 


Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly 
225                 230                 235                 240 


Gly Gly Thr Lys Val Glu Ile Lys 
                245             


<210>  253
<211>  248
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  253

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Ser Ser Asp Leu Val Ser Ser Tyr Leu Asn Trp 
                165                 170                 175     


Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala 
            180                 185                 190         


Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser 
        195                 200                 205             


Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe 
    210                 215                 220                 


Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly 
225                 230                 235                 240 


Gly Gly Thr Lys Val Glu Ile Lys 
                245             


<210>  254
<211>  248
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  254

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Ser Thr Leu Leu Val Ser Ser Tyr Leu Asn Trp 
                165                 170                 175     


Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala 
            180                 185                 190         


Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser 
        195                 200                 205             


Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe 
    210                 215                 220                 


Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly 
225                 230                 235                 240 


Gly Gly Thr Lys Val Glu Ile Lys 
                245             


<210>  255
<211>  246
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  255

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Ser Tyr Val Ser Gly Tyr Leu Asn Trp Tyr Gln 
                165                 170                 175     


Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser 
            180                 185                 190         


Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr 
        195                 200                 205             


Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr 
    210                 215                 220                 


Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly 
225                 230                 235                 240 


Thr Lys Val Glu Ile Lys 
                245     


<210>  256
<211>  248
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  256

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Phe Gly Phe Phe Val Gly Gly Tyr Leu Asn Trp 
                165                 170                 175     


Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala 
            180                 185                 190         


Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser 
        195                 200                 205             


Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe 
    210                 215                 220                 


Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly 
225                 230                 235                 240 


Gly Gly Thr Lys Val Glu Ile Lys 
                245             


<210>  257
<211>  247
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  257

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser 
        115                 120                 125             


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met 
    130                 135                 140                 


Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr 
145                 150                 155                 160 


Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr 
                165                 170                 175     


Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser 
            180                 185                 190         


Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
        195                 200                 205             


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala 
    210                 215                 220                 


Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly 
225                 230                 235                 240 


Gly Thr Lys Val Glu Ile Lys 
                245         


<210>  258
<211>  249
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  258

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser 
        115                 120                 125             


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met 
    130                 135                 140                 


Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr 
145                 150                 155                 160 


Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr 
                165                 170                 175     


Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser 
            180                 185                 190         


Ser Leu His Tyr Val Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly 
        195                 200                 205             


Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp 
    210                 215                 220                 


Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe 
225                 230                 235                 240 


Gly Gly Gly Thr Lys Val Glu Ile Lys 
                245                 


<210>  259
<211>  248
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  259

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser 
        115                 120                 125             


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met 
    130                 135                 140                 


Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr 
145                 150                 155                 160 


Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr 
                165                 170                 175     


Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser 
            180                 185                 190         


Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
        195                 200                 205             


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala 
    210                 215                 220                 


Thr Tyr Tyr Cys Gln Gln Ser Trp Ala Ser Thr Pro Leu Thr Phe Gly 
225                 230                 235                 240 


Gly Gly Thr Lys Val Glu Ile Lys 
                245             


<210>  260
<211>  244
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  260

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        115                 120                 125             


Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln Ser 
    130                 135                 140                 


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
145                 150                 155                 160 


Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys 
                165                 170                 175     


Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln 
            180                 185                 190         


Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe 
        195                 200                 205             


Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr 
    210                 215                 220                 


Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys 
225                 230                 235                 240 


Val Glu Ile Lys 
                


<210>  261
<211>  244
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  261

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        115                 120                 125             


Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln Ser 
    130                 135                 140                 


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
145                 150                 155                 160 


Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys 
                165                 170                 175     


Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln 
            180                 185                 190         


Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe 
        195                 200                 205             


Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr 
    210                 215                 220                 


Cys Gln Gln Ser Tyr Ser Phe Val Leu Thr Phe Gly Gly Gly Thr Lys 
225                 230                 235                 240 


Val Glu Ile Lys 
                


<210>  262
<211>  244
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  262

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        115                 120                 125             


Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln Ser 
    130                 135                 140                 


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
145                 150                 155                 160 


Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys 
                165                 170                 175     


Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln 
            180                 185                 190         


Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe 
        195                 200                 205             


Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr 
    210                 215                 220                 


Cys Gln Gln Ser Tyr Gly Tyr Val Leu Thr Phe Gly Gly Gly Thr Lys 
225                 230                 235                 240 


Val Glu Ile Lys 
                


<210>  263
<211>  247
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  263

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        115                 120                 125             


Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln Ser 
    130                 135                 140                 


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
145                 150                 155                 160 


Arg Ala Ser Gln Ser Ile Gly Pro Phe Leu Ser Tyr Leu Asn Trp Tyr 
                165                 170                 175     


Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser 
            180                 185                 190         


Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
        195                 200                 205             


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala 
    210                 215                 220                 


Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly 
225                 230                 235                 240 


Gly Thr Lys Val Glu Ile Lys 
                245         


<210>  264
<211>  244
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  264

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        115                 120                 125             


Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln Ser 
    130                 135                 140                 


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
145                 150                 155                 160 


Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys 
                165                 170                 175     


Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln 
            180                 185                 190         


Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe 
        195                 200                 205             


Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr 
    210                 215                 220                 


Cys Gln Gln Ser Trp Gly Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys 
225                 230                 235                 240 


Val Glu Ile Lys 
                


<210>  265
<211>  247
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  265

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser Gly Gly Gly Gly Ser 
        115                 120                 125             


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met 
    130                 135                 140                 


Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr 
145                 150                 155                 160 


Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr 
                165                 170                 175     


Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser 
            180                 185                 190         


Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
        195                 200                 205             


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala 
    210                 215                 220                 


Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly 
225                 230                 235                 240 


Gly Thr Lys Val Glu Ile Lys 
                245         


<210>  266
<211>  250
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  266

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser Gly Gly Gly Gly Ser 
        115                 120                 125             


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met 
    130                 135                 140                 


Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr 
145                 150                 155                 160 


Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Gly Leu Ser Tyr Leu 
                165                 170                 175     


Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
            180                 185                 190         


Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser 
        195                 200                 205             


Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu 
    210                 215                 220                 


Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
225                 230                 235                 240 


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
                245                 250 


<210>  267
<211>  250
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  267

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ser Thr Ser Trp Val Asn Phe Pro Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser Gly Gly Gly Gly Ser 
        115                 120                 125             


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met 
    130                 135                 140                 


Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr 
145                 150                 155                 160 


Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Gly Val Ser Tyr Leu 
                165                 170                 175     


Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
            180                 185                 190         


Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser 
        195                 200                 205             


Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu 
    210                 215                 220                 


Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
225                 230                 235                 240 


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
                245                 250 


<210>  268
<211>  244
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  268

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Thr Val Lys Ile Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Tyr Met His Trp Val Gln Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Leu Val Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Glu Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Leu Leu Ser Gly Trp Tyr Ile Asp Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        115                 120                 125             


Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln Ser 
    130                 135                 140                 


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
145                 150                 155                 160 


Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys 
                165                 170                 175     


Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln 
            180                 185                 190         


Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe 
        195                 200                 205             


Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr 
    210                 215                 220                 


Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys 
225                 230                 235                 240 


Val Glu Ile Lys 
                


<210>  269
<211>  248
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  269

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Leu Tyr Tyr Asp Ile Leu Thr Gly Tyr Pro Asp Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly 
        115                 120                 125             


Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln 
    130                 135                 140                 


Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val 
145                 150                 155                 160 


Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp 
                165                 170                 175     


Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala 
            180                 185                 190         


Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser 
        195                 200                 205             


Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe 
    210                 215                 220                 


Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly 
225                 230                 235                 240 


Gly Gly Thr Lys Val Glu Ile Lys 
                245             


<210>  270
<211>  244
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  270

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg Asp Gly Gly Asn Trp Tyr Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        115                 120                 125             


Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln Ser 
    130                 135                 140                 


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
145                 150                 155                 160 


Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys 
                165                 170                 175     


Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln 
            180                 185                 190         


Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe 
        195                 200                 205             


Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr 
    210                 215                 220                 


Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys 
225                 230                 235                 240 


Val Glu Ile Lys 
                


<210>  271
<211>  245
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  271

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Asp 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Val Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asn Thr Asp Pro Gln Leu Glu Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln 
    130                 135                 140                 


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
145                 150                 155                 160 


Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln 
                165                 170                 175     


Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu 
            180                 185                 190         


Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp 
        195                 200                 205             


Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr 
    210                 215                 220                 


Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr 
225                 230                 235                 240 


Lys Val Glu Ile Lys 
                245 


<210>  272
<211>  243
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  272

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Ser Ser Thr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Asp Tyr Ser Ser Glu Tyr Phe Gln His Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
        115                 120                 125             


Ser Gly Gly Gly Gly Ser Gly Gly Asp Ile Gln Met Thr Gln Ser Pro 
    130                 135                 140                 


Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg 
145                 150                 155                 160 


Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro 
                165                 170                 175     


Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser 
            180                 185                 190         


Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
        195                 200                 205             


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
    210                 215                 220                 


Gln Gln Ser Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val 
225                 230                 235                 240 


Glu Ile Lys 
            


<210>  273
<211>  267
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment

<400>  273

Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala 
1               5                   10                  15      


Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly 
            20                  25                  30          


Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Phe Trp Val 
        35                  40                  45              


Leu Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu Leu Val Thr 
    50                  55                  60                  


Val Ala Phe Ile Ile Phe Trp Val Arg Ser Lys Arg Ser Arg Leu Leu 
65                  70                  75                  80  


His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg 
                85                  90                  95      


Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg 
            100                 105                 110         


Ser Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe 
        115                 120                 125             


Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg 
    130                 135                 140                 


Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser 
145                 150                 155                 160 


Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr 
                165                 170                 175     


Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys 
            180                 185                 190         


Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn 
        195                 200                 205             


Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu 
    210                 215                 220                 


Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly 
225                 230                 235                 240 


His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr 
                245                 250                 255     


Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg 
            260                 265         


<210>  274
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  274

Ala Arg Asp Gly Asp Val Pro Tyr Trp Tyr Phe Asp Leu 
1               5                   10              


<210>  275
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  275

Ala Thr Asp Leu Tyr Ser Ser Ser Trp Tyr Cys Asp Ala Phe Asp Ile 
1               5                   10                  15      


<210>  276
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  276

Ala Arg Ile Pro Phe Gly Asp Trp Trp Tyr Phe Asp Leu 
1               5                   10              


<210>  277
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  277

Ala Arg Asp Leu Tyr Tyr Asp Ile Leu Thr Gly Tyr Pro Asp Ala Phe 
1               5                   10                  15      


Asp Ile 
        


<210>  278
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  278

Ala Arg Arg Asp Gly Gly Asn Trp Tyr Phe Asp Leu 
1               5                   10          


<210>  279
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  279

Ala Arg Asn Thr Asp Pro Gln Leu Glu Trp Tyr Phe Asp Leu 
1               5                   10                  


<210>  280
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment heavy chain 
       CDR3

<400>  280

Ala Arg Asp Asp Tyr Ser Ser Glu Tyr Phe Gln His 
1               5                   10          


<210>  281
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment light chain 
       CDR3

<400>  281

Gln Gln Ser Tyr Ser Phe Val Leu Thr 
1               5                   


<210>  282
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-MAGE-A3 antibody or antigen-binding fragment light chain 
       CDR3

<400>  282

Gln Gln Ser Tyr Gly Tyr Val Leu Thr 
1               5                   


<210>  283
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  283

Phe Leu Trp Gly Pro Arg Ala Leu Ala 
1               5                   


<210>  284
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  284

Phe Leu Trp Gly Pro Arg Ala Leu Ile 
1               5                   


<210>  285
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  285

Phe Leu Trp Gly Ser Lys Ala His Ala 
1               5                   


<210>  286
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  286

Phe Leu Trp Gly Pro Arg Ala His Ala 
1               5                   


<210>  287
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  287

Ser Tyr Ala Ile Ser 
1               5   


<210>  288
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  288

Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  289
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  289

Asp Met Asp Thr Phe Ser Met Val Thr Leu Phe Asp Tyr 
1               5                   10              


<210>  290
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  290

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  291
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  291

Arg Ala Ser Val Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  292
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  292

Arg Ala Ser Leu Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  293
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  293

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  294
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  294

Ala Ala Ser Ser Leu Val Gln Ser 
1               5               


<210>  295
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  295

Ala Ala Cys Ser Leu Gln Ser 
1               5           


<210>  296
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  296

Ala Ala Tyr Val Ser Ser Leu Gln Ser 
1               5                   


<210>  297
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  297

Ala Ala Ser Val Ser Ser Leu Gln Ser 
1               5                   


<210>  298
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  298

Ala Ala Glu Thr Leu Gln Ser 
1               5           


<210>  299
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  299

Ala Ala Ser Gly Ile Lys Ala Ser Ser Leu Gln Ser 
1               5                   10          


<210>  300
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  300

Ala Ala Val Ser Ser Leu Gln Ser 
1               5               


<210>  301
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  301

Gln Gln Ser Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  302
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  302

Gln Gln Ser Tyr Ser Ser Pro Leu Thr 
1               5                   


<210>  303
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  303

Gln Gln Ser Tyr Arg Thr Pro Leu Thr 
1               5                   


<210>  304
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  304

Gln Gln Ser Tyr Leu Thr Pro Leu Thr 
1               5                   


<210>  305
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  305

Gln Gln Ser Tyr Ser Pro Pro Leu Thr 
1               5                   


<210>  306
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  306

Gln Gln Ser Tyr Ser Trp Pro Leu Thr 
1               5                   


<210>  307
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  307

Gln Gln Ser Tyr Met Thr Pro Leu Thr 
1               5                   


<210>  308
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  308

Gln Gln Ser Trp Asp Thr Pro Leu Thr 
1               5                   


<210>  309
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  309

Gln Gln Ile Val Ser Thr Pro Leu Thr 
1               5                   


<210>  310
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  310

Gln Gln Ser Trp Ser Thr Pro Leu Thr 
1               5                   


<210>  311
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  311

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Met Asp Thr Phe Ser Met Val Thr Leu Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  312
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  312

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  313
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  313

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Val Gln Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  314
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  314

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Cys Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  315
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  315

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ser Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  316
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  316

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Arg Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  317
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  317

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Leu Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  318
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  318

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Val Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  319
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  319

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Leu Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  320
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  320

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  321
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  321

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Ser Gly Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  322
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  322

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Pro Pro Leu 
                85                  90                  95      


Ser Gly Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  323
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  323

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Glu Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  324
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  324

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Val Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe 
    50                  55                  60                  


Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu 
65                  70                  75                  80  


Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr 
                85                  90                  95      


Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  325
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  325

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ile Val Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  326
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  326

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Trp Asp Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  327
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  327

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Leu Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  328
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  328

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Trp Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  329
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa at position 4 can be Leu, Gln, or Val

<400>  329

Arg Ala Ser Xaa Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  330
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa at position 3 can be absent, Ser or Tyr

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa at position 4 can be absent, Gly, or Val

<220>
<221>  MISC_FEATURE
<222>  (5)..(7)
<223>  Amino acids at positions 5 to 7 can be absent

<220>
<221>  MISC_FEATURE
<222>  (5)..(7)
<223>  Xaa at positions 5-7 may be Ile Lys Ala or absent

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa at position 8 can be Cys, Glu, or Ser

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa at position 9 can be Ser or Thr

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa at position 11 can be absent or Val

<400>  330

Ala Ala Xaa Xaa Xaa Xaa Xaa Xaa Xaa Leu Xaa Gln Ser 
1               5                   10              


<210>  331
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa at position 3 can be Ile or Ser

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa at position 4 can be Val, Trp, or Tyr

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa at position 5 can be Ser, Asp, Leu, Met, or Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa at position 6 can be Thr, Pro, Ser, or Trp

<400>  331

Gln Gln Xaa Xaa Xaa Xaa Pro Leu Thr 
1               5                   


<210>  332
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  332

Lys Val Ala Glu Leu Val His Phe Leu 
1               5                   


<210>  333
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  333

Ser Ala Ala Glu Leu Val His Phe Leu 
1               5                   


<210>  334
<211>  267
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 related peptide

<400>  334

Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala 
1               5                   10                  15      


Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly 
            20                  25                  30          


Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Phe Trp Val 
        35                  40                  45              


Leu Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu Leu Val Thr 
    50                  55                  60                  


Val Ala Phe Ile Ile Phe Trp Val Arg Ser Lys Arg Ser Arg Leu Leu 
65                  70                  75                  80  


His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg 
                85                  90                  95      


Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg 
            100                 105                 110         


Ser Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe 
        115                 120                 125             


Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg 
    130                 135                 140                 


Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser 
145                 150                 155                 160 


Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr 
                165                 170                 175     


Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys 
            180                 185                 190         


Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn 
        195                 200                 205             


Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu 
    210                 215                 220                 


Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly 
225                 230                 235                 240 


His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr 
                245                 250                 255     


Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg 
            260                 265         


<210>  335
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Off-target MAGE-A1/A4/A8 peptide

<400>  335

Phe Leu Trp Gly Pro Arg Ala Leu Ala 
1               5                   


<210>  336
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Off-target MAGE-A2/A6 peptide

<400>  336

Phe Leu Trp Gly Pro Arg Ala Leu Ile 
1               5                   


<210>  337
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Off-target MAGE-A9 peptide

<400>  337

Phe Leu Trp Gly Ser Lys Ala His Ala 
1               5                   


<210>  338
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Off-target MAGE-A10/A11 peptide

<400>  338

Phe Leu Trp Gly Pro Arg Ala His Ala 
1               5                   


<210>  339
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A1 peptide

<400>  339

Lys Val Ala Asp Leu Val Gly Phe Leu 
1               5                   


<210>  340
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A2 peptide

<400>  340

Lys Met Val Glu Leu Val His Phe Leu 
1               5                   


<210>  341
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A4 peptide

<400>  341

Lys Val Asp Glu Leu Ala His Phe Leu 
1               5                   


<210>  342
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A5 peptide

<400>  342

Lys Val Ala Asp Leu Ile His Phe Leu 
1               5                   


<210>  343
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A6 peptide

<400>  343

Lys Val Ala Lys Leu Val His Phe Leu 
1               5                   


<210>  344
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A8 Peptide

<400>  344

Lys Val Ala Glu Leu Val Arg Phe Leu 
1               5                   


<210>  345
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A10 peptide

<400>  345

Lys Val Thr Asp Leu Val Gln Phe Leu 
1               5                   


<210>  346
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A11 peptide

<400>  346

Lys Ile Ile Asp Leu Val His Leu Leu 
1               5                   


<210>  347
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A12 peptide

<400>  347

Lys Met Ala Glu Leu Val His Phe Leu 
1               5                   


<210>  348
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EPS8L2 peptide

<400>  348

Ser Ala Ala Glu Leu Val His Phe Leu 
1               5                   


<210>  349
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EPS8 peptide

<400>  349

Ser Ala Ala Asp Leu Val His Phe Leu 
1               5                   


<210>  350
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-C3 peptide

<400>  350

Lys Val Ala Glu Leu Val Gln Phe Leu 
1               5                   


<210>  351
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-F1 peptide

<400>  351

Thr Val Ala Glu Leu Val Gln Phe Val 
1               5                   


<210>  352
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-B18 peptide

<400>  352

Lys Val Val Ser Leu Val His Phe Leu 
1               5                   


<210>  353
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MRVI1 peptide

<400>  353

Lys Leu Glu Glu Leu Val His Phe Leu 
1               5                   


<210>  354
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DDX28 peptide

<400>  354

Lys Val Ala Glu Leu Val His Ile Leu 
1               5                   


<210>  355
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PPP2R1B peptide

<400>  355

Gly Ile Ala Glu Leu Val His Phe Ser 
1               5                   


<210>  356
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  A1/A4/A8 peptide

<400>  356

Phe Leu Trp Gly Pro Arg Ala Leu Ala 
1               5                   


<210>  357
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  A2/A6 peptide

<400>  357

Phe Leu Trp Gly Pro Arg Ala Leu Ile 
1               5                   


<210>  358
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  A9 peptide

<400>  358

Phe Leu Trp Gly Ser Lys Ala His Ala 
1               5                   


<210>  359
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  A10/11 peptide

<400>  359

Phe Leu Trp Gly Pro Arg Ala His Ala 
1               5                   


<210>  360
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Pan-MAGE A peptide

<400>  360

Phe Leu Trp Gly Pro Arg Ala Leu 
1               5               


<210>  361
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-H1 peptide

<400>  361

Phe Phe Trp Gly Pro Arg Ala His Val 
1               5                   


<210>  362
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EPS8L2 peptide

<400>  362

Ser Ala Ala Glu Leu Val His Phe Leu 
1               5                   


<210>  363
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-E2 pep1 peptide

<400>  363

Phe Leu Trp Gly Ser Arg Ala His Arg Glu 
1               5                   10  


<210>  364
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-E2 pep2 peptide

<400>  364

Phe Leu Trp Gly Ser Arg Ala His Arg 
1               5                   


<210>  365
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PCSK1Na peptide

<400>  365

Leu Leu Trp Gly Pro Arg Ala Gly Gly Val 
1               5                   10  


<210>  366
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PCSK1Nb peptide

<400>  366

Leu Leu Trp Gly Pro Arg Ala Gly Gly 
1               5                   


<210>  367
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IMMP2L-pep1 peptide

<400>  367

Phe Leu Trp Phe Ile Val Val Leu Gly 
1               5                   


<210>  368
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IMMP2L-pep2 peptide

<400>  368

Phe Leu Trp Phe Ile Val Val Leu 
1               5               


<210>  369
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IgG VH peptide

<400>  369

Phe Ala Tyr Trp Gly Pro Arg Ala Leu 
1               5                   


<210>  370
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A12 peptide

<400>  370

Lys Met Ala Glu Leu Val His Phe Leu 
1               5                   


<210>  371
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A9 nucleotide

<400>  371
tgaccaggag gacaggagcc ccaa                                              24


<210>  372
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A1 nucleotide

<400>  372
caacccagag gacaggattc cctg                                              24


<210>  373
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 nucleotide

<400>  373
tgacctggag gaccag                                                       16


<210>  374
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A4 nucleotide

<400>  374
caaccggagg acaggattcc ctg                                               23


<210>  375
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A5 nucleotide

<400>  375
tgaccaggat caccaggaag ctccagagga tccccag                                37


<210>  376
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A6 nucletotide

<400>  376
tgacgtggag gaacag                                                       16


<210>  377
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A10 nucleotide

<400>  377
agagcaagag gtcaagagct gtgg                                              24


<210>  378
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A11 nucleotide

<400>  378
caacctggag gacaggagtc ccag                                              24


<210>  379
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A12 nucleotide

<400>  379
ggaccttttc ttcagagggt gactcaggtc aacacag                                37


<210>  380
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A2 nucleotide

<400>  380
tgaccttgtt ttcagaaggt gactcaggtc aacacag                                37


<210>  381
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A2B nucleotide

<400>  381
tgaccttgtt ttcagaaggt gactcaggtc aacacag                                37


<210>  382
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A10 nucleotide

<400>  382
gaaccttgct ctcagagggt gactcaagtc aacacag                                37


<210>  383
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MAGE-A12

<400>  383
ggaccttttc ttcagagggt gactcaggtc aacacag                                37


